F18.920
Inhalant use, unspecified with intoxication, uncomplicated
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F18.920 refers to cases where an individual has used inhalants, but the specific substance is not identified, resulting in uncomplicated intoxication. Inhalant use involves inhaling vapors from various household or industrial products to achieve a psychoactive effect. This type of substance use can lead to immediate intoxication with potential health risks. The diagnosis indicates that although intoxication has occurred, there are no complicating conditions such as injuries or long-term health issues at the time of diagnosis.
Causes & Symptoms
Clinical Causes: Availability of household products such as glue, aerosol sprays, paint thinners, and computer cleaners Peer pressure or social influences encouraging the use of inhalants Mental health disorders like depression or anxiety that lead individuals toward substance use Curiosity or experimentation, especially among adolescents and teenagers Lack of awareness about the health risks associated with inhalant use
Key Symptoms: Euphoria or feelings of intoxication Dizziness or lightheadedness Headaches or nausea Impaired judgment and coordination Slurred speech Muscle weakness Confusion or disorientation In some cases, hallucinations or seizures
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves clinical assessment based on reported inhalant use and observed symptoms. Healthcare providers may also perform physical examinations and laboratory tests to rule out other causes of symptoms. Since the condition is reported as uncomplicated, no additional health issues are identified at diagnosis. It is important to recognize the signs early and obtain an accurate history to guide appropriate care.
Treatment Protocols: Treatment for inhalant intoxication typically includes supportive care, such as ensuring a safe environment, monitoring vital signs, and managing symptoms. Medical intervention might involve hydration, oxygen therapy, or medications to control seizures if they occur. Long-term strategies focus on preventing future inhalant use through counseling, behavioral therapies, and education about the risks associated with inhalants. In some cases, referral to specialists such as addiction counselors or mental health professionals is recommended.
Clinical Advice & FAQs
Billing Guidance
Is F18.920 a billable ICD-10 code?
Yes, F18.920 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.920?
Clinical documentation must specify the nature of Inhalant use, unspecified with intoxication, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference